Angiology最新文献_第8页

Pathophysiology and Genetic Associations of Varicose Veins: A Narrative Review. 静脉曲张的病理生理学和遗传关联：叙述性综述。

IF 2.2 3区医学

Angiology Pub Date : 2025-08-01 Epub Date: 2024-01-16 DOI: 10.1177/00033197241227598

Tao Chen, Peng Liu, Chenguang Zhang, Song Jin, Yuhu Kong, Yanan Feng, Ziqiang Sun

引用次数: 0

A Comparison of Carotid Ultrasound and Coronary Optical Coherence Tomography in Assessing Plaque Morphology in Patients with Chronic Coronary Syndrome. 颈动脉超声与冠状动脉光学相干断层扫描评估慢性冠脉综合征患者斑块形态的比较。

IF 2.2 3区医学

Angiology Pub Date : 2025-07-30 DOI: 10.1177/00033197251355336

Mehmet Ali Cetiner, Marc Vorpahl, Melchior Seyfarth, Ulrich Wiederhold, Juliane Sophie Yu, Rojvan Bilgin, Ramazan Gökmen Turan

{"title":"A Comparison of Carotid Ultrasound and Coronary Optical Coherence Tomography in Assessing Plaque Morphology in Patients with Chronic Coronary Syndrome.","authors":"Mehmet Ali Cetiner, Marc Vorpahl, Melchior Seyfarth, Ulrich Wiederhold, Juliane Sophie Yu, Rojvan Bilgin, Ramazan Gökmen Turan","doi":"10.1177/00033197251355336","DOIUrl":"https://doi.org/10.1177/00033197251355336","url":null,"abstract":"Atherosclerosis is a predominant cause of cardiovascular events and the accurate assessment of plaque morphology is crucial for risk stratification and treatment planning. Carotid ultrasound (CUS) and coronary artery optical coherence tomography (OCT) are valuable imaging modalities for evaluating atherosclerotic plaques. This study aimed to compare the reliability of CUS and OCT in assessing plaque morphology and atherosclerosis in patients with chronic coronary syndrome. Forty-six patients with chronic coronary syndrome underwent OCT to evaluate coronary plaques and CUS to assess carotid plaques. The findings showed that both imaging techniques detected the presence of plaques, with OCT providing more detailed information on coronary plaque morphology compared with CUS. OCT and CUS measurements demonstrated significant correlations in lumen stenosis, plaque sizes, and representations of calcified plaques. Furthermore, distinct differences were observed in plaque distribution and characteristics between the coronary and carotid arteries. Certain cardiovascular risk factors such as diabetes, arterial hypertension, and obesity were associated with specific plaque properties identified by OCT. This study underscores the complementary roles of OCT and CUS in assessing atherosclerosis and plaque vulnerability in patients with chronic coronary syndrome, providing valuable insights for clinical management and treatment strategies.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197251355336"},"PeriodicalIF":2.2,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144740977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to the Letter Regarding: "Prognostic Value of the Triglycerides-Glucose Index for Major-Adverse-Cardiac Events in Severe Aortic Stenosis Patients After TAVI". 关于“甘油三酯-葡萄糖指数对TAVI后严重主动脉瓣狭窄患者主要心脏不良事件的预后价值”的回复。

IF 2.2 3区医学

Angiology Pub Date : 2025-07-29 DOI: 10.1177/00033197251363663

Emine Altuntas, Abidin Emre Tırnaksız, Kadir Sadıkoğlu, Serkan Aslan, Gökhan Demirci, Ahmet Arif Yalcın, Ali Kemal Kalkan, Fatih Uzun, Ibrahim Faruk Akturk, Omer Celik, Mehmet Ertürk

引用次数: 0

Cardiovascular Oncology: Consensus Statements Are Still Lacking to Improve the Management of Side-Effects of Old and New Chemotherapeutic Agents. 心血管肿瘤学：在改进新旧化疗药物副作用管理方面仍缺乏共识声明。

IF 2.2 3区医学

Angiology Pub Date : 2025-07-29 DOI: 10.1177/00033197251356583

Antonio V Sterpetti, Francesca Miceli, Alessia Di Girolamo, Immacolata Iannone, Paolo Sapienza, Luca Di Marzo

{"title":"Cardiovascular Oncology: Consensus Statements Are Still Lacking to Improve the Management of Side-Effects of Old and New Chemotherapeutic Agents.","authors":"Antonio V Sterpetti, Francesca Miceli, Alessia Di Girolamo, Immacolata Iannone, Paolo Sapienza, Luca Di Marzo","doi":"10.1177/00033197251356583","DOIUrl":"https://doi.org/10.1177/00033197251356583","url":null,"abstract":"Significant advances in diagnostic methods and better life-expectancy have resulted in increased number of patients with cardiovascular diseases and cancer. Elderly patients are at risk for both diseases, and the treatment of patients with cardiovascular and oncologic problems represents a daily clinical challenge, considering the heterogeneity of clinical situations. The present review underlines the complexity of cardiovascular oncology. In the last 5 years >18 new drugs against cancer, with possible cardiovascular side-effects, were approved by the Food and Drug Administration. Several new drugs are under evaluation in multicenter prospective studies, and some of these agents have potential cardiovascular side-effects. This review analyzes the difficulties for cardiovascular specialists to keep updated regarding the possible side-effects of new chemotherapeutic agents. The analysis of the mechanisms involved in cancer occurrence and progression are a field of research in continuous development with new discoveries, and technologies applied at developing effective chemotherapeutic drugs. Several recommendations have been proposed by the American Heart Association and European Society of Cardiology, promoting the need for close collaboration between cardiologists, surgeons, and oncologists. It is important to develop strategies to support training in cardiovascular oncology.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197251356583"},"PeriodicalIF":2.2,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144726948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The Influence of Smoking and Systemic Inflammation on Carotid Artery Disease: A Cross-Sectional Analysis of Stenosis, Plaque Surface Characteristics. 吸烟和全身炎症对颈动脉疾病的影响：狭窄、斑块表面特征的横断面分析。

IF 2.6 3区医学

Angiology Pub Date : 2025-07-23 DOI: 10.1177/00033197251356577

Taylan Altiparmak, Hale Zeynep Batur Caglayan, Sevcihan Kesen Ozbek, Fatih Oncu, Atiye Cenay Karabork Kilic, Tugba Erdogan, Serife Yaymaci, Bijen Nazliel

{"title":"The Influence of Smoking and Systemic Inflammation on Carotid Artery Disease: A Cross-Sectional Analysis of Stenosis, Plaque Surface Characteristics.","authors":"Taylan Altiparmak, Hale Zeynep Batur Caglayan, Sevcihan Kesen Ozbek, Fatih Oncu, Atiye Cenay Karabork Kilic, Tugba Erdogan, Serife Yaymaci, Bijen Nazliel","doi":"10.1177/00033197251356577","DOIUrl":"https://doi.org/10.1177/00033197251356577","url":null,"abstract":"The role of inflammation in carotid plaque formation and instability has been highlighted in recent studies. We assessed the significance of smoking status on systemic inflammation and their relationships with carotid stenosis and carotid plaque surface characteristics. A total of 822 patients diagnosed with carotid artery stenosis were recruited and evaluated with systemic inflammation indices according to smoking status. Subgroups were balanced in terms of gender, age, and additional diseases. Systemic inflammation indices were found to be substantially higher in smokers (P < .001) and in patients with irregular-ulcerated surface plaques (P < .001). Plaque surfaces were more irregular and ulcerated in smokers (P < .001). No difference was detected between stenosis degree and smoking status or with systemic inflammation (P > .05). Pan-immune-inflammatory value (PIV) had a strong correlation with both smoking and plaque instability (P < .001, r = .771). Additionally, high PIV levels displayed a significant risk augmentation for irregular/ulcerated surface plaques (P < .001, Odds Ratio (OR):13.796; 95%CI, 5.647-33.701). These findings suggest that in patients with carotid atherosclerotic stenosis, systemic inflammatory markers especially PIV, alongside with plaque surface characteristics, may serve as valuable tools for evaluating and monitoring plaque inflammation. This may lead to more personalized and effective treatment strategies, particularly in smokers.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197251356577"},"PeriodicalIF":2.6,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144688786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Endocan, a Potential Biomarker of Endothelial Dysfunction: A Brief Overview. 内啡肽，内皮功能障碍的潜在生物标志物：概述。

IF 2.6 3区医学

Angiology Pub Date : 2025-07-22 DOI: 10.1177/00033197251356576

Megha Bidlan, Mohit Kumar, Anurag Bhargava, Vrinda Goel, Vijay Kumar

{"title":"Endocan, a Potential Biomarker of Endothelial Dysfunction: A Brief Overview.","authors":"Megha Bidlan, Mohit Kumar, Anurag Bhargava, Vrinda Goel, Vijay Kumar","doi":"10.1177/00033197251356576","DOIUrl":"https://doi.org/10.1177/00033197251356576","url":null,"abstract":"Endocan (endothelial cell-specific molecule 1, ESM-1), is a proteoglycan produced by the vascular endothelium that modulates cellular functions such as adhesion, migration, and proliferation. Elevated serum endocan levels are associated with autoimmune and inflammatory disorders, acting as a marker of endothelial activation and dysfunction. This brief overview considers endocan's role in HTN, cirrhosis, diabetes, peripheral arterial disease (PAD), coronavirus Disease 2019 (COVID-19), erectile dysfunction (ED), and psoriasis vulgaris. Data were gathered from research reporting endocan levels, illness markers, and clinical outcomes. Elevated endocan levels are associated with endothelial dysfunction, which contributes to diabetes complications and associated with vascular endothelial growth factor A (VEGF-A) activation. In HTN, endocan promotes inflammatory signaling and lymphocyte infiltration. In liver disease, particularly cirrhosis, elevated levels correlate with hepatic fibrosis and poor prognosis. PAD patients show raised endocan correlating with disease severity. COVID-19 studies suggest coronavirus induces endotheliitis. In ED, higher endocan levels are linked with endothelial dysfunction and impaired vascular reactivity, serving as a potential biomarker for vascular-related ED. In psoriasis vulgaris, endocan levels correlate with disease severity and cardiovascular risk. The present brief overview supports that monitoring endocan levels may improve treatment and prognosis. Further research is required to define its clinical potential.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197251356576"},"PeriodicalIF":2.6,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144688784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: Association Between Anemia and Prognosis in Patients With Acute Coronary Syndrome and Atrial Fibrillation. 信函：急性冠状动脉综合征和心房颤动患者贫血与预后的关系。

IF 2.6 3区医学

Angiology Pub Date : 2025-07-22 DOI: 10.1177/00033197251360684

Hilal Tunçer, Özden Seçkin, Serkan Ünlü

引用次数: 0

Latent Class Analysis Identifies Distinct Patient Phenotypes Associated With Mistaken Treatment Decisions and Adverse Outcomes in Coronary Artery Disease. 潜在类分析确定与冠状动脉疾病错误治疗决策和不良结局相关的不同患者表型。

IF 2.6 3区医学

Angiology Pub Date : 2025-07-19 DOI: 10.1177/00033197251350182

Jing Qi, Zhiqiang Wang, Xiaoteng Ma, Zhijian Wang, Yueping Li, Lixia Yang, Dongmei Shi, Yujie Zhou

{"title":"Latent Class Analysis Identifies Distinct Patient Phenotypes Associated With Mistaken Treatment Decisions and Adverse Outcomes in Coronary Artery Disease.","authors":"Jing Qi, Zhiqiang Wang, Xiaoteng Ma, Zhijian Wang, Yueping Li, Lixia Yang, Dongmei Shi, Yujie Zhou","doi":"10.1177/00033197251350182","DOIUrl":"https://doi.org/10.1177/00033197251350182","url":null,"abstract":"This study aimed to identify patient characteristics linked to mistaken treatments and major adverse cardiovascular events (MACE) in percutaneous coronary intervention (PCI) for coronary artery disease (CAD) using deep learning-based fractional flow reserve (DEEPVESSEL-FFR, DVFFR). A retrospective cohort of 3,840 PCI patients was analyzed using latent class analysis (LCA) based on eight factors. Mistaken treatment was defined as negative DVFFR patients undergoing revascularization or positive DVFFR patients not receiving it. MACE included all-cause mortality, rehospitalization for unstable angina, and non-fatal myocardial infarction. Patients were classified into comorbidities (Class 1), smoking-drinking (Class 2), and relatively healthy (Class 3) groups. Mistaken treatment was highest in Class 2 (15.4% vs. 6.7%, P < .001), while MACE was highest in Class 1 (7.0% vs. 4.8%, P < .001). Adjusted analyses showed increased mistaken treatment risk in Class 1 (OR 1.96; 95% CI 1.49-2.57) and Class 2 (OR 1.69; 95% CI 1.28-2.25) compared with Class 3. Class 1 also had higher MACE risk (HR 1.53; 95% CI 1.10-2.12). In conclusion, comorbidities and smoking-drinking classes had higher mistaken treatment and MACE risks compared with the relatively healthy class.","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197251350182"},"PeriodicalIF":2.6,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144666950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter: Is AISI a Reliable Predictor of Prognosis in Patients With CAD and CKD? 信函：AISI是CAD和CKD患者预后的可靠预测因子吗？

IF 2.6 3区医学

Angiology Pub Date : 2025-07-18 DOI: 10.1177/00033197251359696

Jian-Yong Wang, Ai-Min Li, Na Gao

引用次数: 0

Letter: Role of AISI in Prognosis of CAD With CKD: An Inflammatory Perspective. 信：AISI在CAD合并CKD的预后中的作用：一个炎症的角度。

IF 2.6 3区医学

Angiology Pub Date : 2025-07-14 DOI: 10.1177/00033197251359695

Nuo Li, De-Gang Mo

引用次数: 0